Expert Interview
A Third Look: Discussing Icosavax's Interim Phase 2 results for combination VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults
Ticker(s): AZN, ICVXInstitution: Family Care of Fox Cities
- Board Certified Family Medicine Physician
- Recommends meningitis to roughly 20 patients weekly
- Familiar with the phase 3 MenABCWY Noninferiority study
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
